Americhem Appoints Kilian Lamprecht as Vice President of Mergers & Acquisitions to Accelerate Strategic Growth
18.3.2026 13:00:00 EET | Business Wire | Press release
Americhem, a global leader in polymer solutions, today announced that Kilian Lamprecht has joined the company as Vice President of Mergers & Acquisitions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260317304976/en/
Kilian Lamprecht, Vice President of Mergers & Acquisitions, Americhem
Lamprecht brings extensive experience in corporate development and integration within global industrial and technology organizations. He will work closely with Americhem’s executive leadership team and investment partner PPC to identify and execute strategic acquisitions, partnerships and portfolio investments that expand the company’s capabilities, product portfolio and geographic reach.
“Americhem has a long history of disciplined growth and innovation in materials science,” said John Richard, CEO of Americhem. “With the support of PPC, we are expanding our ability to pursue strategic acquisitions that strengthen our technology platform, broaden our geographic footprint and deepen our presence in key markets. Kilian brings the rigor, global perspective and transaction experience needed to help us identify the right opportunities and integrate them successfully as we accelerate our next phase of growth.”
Lamprecht’s international background aligns closely with Americhem’s global operations. He has lived, studied and worked across North America, Europe and Asia, bringing cross-border experience that supports the company’s international growth strategy. He holds a Master of Science in Management from HHL Leipzig Graduate School of Management and completed international studies at Peking University’s Guanghua School of Management.
Americhem continues to invest in both organic innovation and strategic acquisitions as it expands its global presence across healthcare, transportation and other advanced materials markets. With the support of PPC, the company is accelerating investments in technology, global manufacturing capabilities and partnerships that strengthen its position as a trusted materials solutions provider.
About Americhem
Americhem is an innovative, technology-driven leader in the global polymer industry. Its foundation is built around delivering Performance, Solutions and Trust through close collaboration with customers. All of the company's products are backed by complete technical support that ensures quality, reliability, and value. Americhem operates 10 manufacturing plants and maintains sales offices throughout the world. For more information, visit www.Americhem.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260317304976/en/
Contacts
Stephanie Sulcer
Director, Marketing & Communications
sasulcer@americhem.com
+1 (330) 810-0977
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Veracode Expands Industry-Leading Fix with AI-Powered SCA Remediation to Combat Software Supply Chain Risk18.3.2026 14:00:00 EET | Press release
RSA Conference (booth #435)--Veracode, the global leader in application risk management, today announced Veracode Fix for Software Composition Analysis (SCA), an AI-powered solution to address software supply chain risk. The enhanced automated remediation engine—the next evolution of Veracode’s industry-leading Fix solution—enables organizations to detect and remediate open-source vulnerabilities easily, before code reaches production. Designed to integrate seamlessly into existing developer workflows, it delivers third-party updates and first-party code refactoring without breaking builds or disrupting development. In 2025, software supply chain breaches accounted for 30 percent of external attacks. Meanwhile Veracode’s 2026 State of Software Security (SoSS) Report revealed 82 percent of organizations struggle with escalating security debt, largely due to open-source dependencies. Veracode Fix for SCA addresses both challenges directly. Leveraging deep, contextual analysis, the soluti
Bentley Systems Announces 2026 Year in Infrastructure Event and YII Awards Honoring the World’s Most Innovative Use of Infrastructure Engineering Software18.3.2026 14:00:00 EET | Press release
Bentley Systems, Incorporated (NASDAQ: BSY), the infrastructure engineering software company, today announced the opening of submissions for the Year in Infrastructure event and YII Awards program, which recognizes digital innovation in how infrastructure is designed, built, and operated using Bentley software. Submissions will be accepted through May 3, at 11:59 p.m. EDT. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260318559906/en/ Bentley Systems announced the opening of submissions for the Year in Infrastructure event and YII Awards program, which recognizes digital innovation in how infrastructure is designed, built, and operated using Bentley software. Submissions will be accepted through May 3, at 11:59 p.m. EDT. (Image courtesy of Bentley Systems, with credit to PT. Wika Tirta Jaya Jatiluhur (WTJJ), Voyants Solutions Private Limited, EGIS, and Baosteel Engineering & Technology Group Co., Ltd.) “Originally, the Bent
Armis Appoints Simon Mouyal as Chief Marketing Officer18.3.2026 14:00:00 EET | Press release
Armis, the cyber exposure management & security company, today announced the appointment of Simon Mouyal as Chief Marketing Officer. In this role, Mouyal will oversee Armis’ global marketing strategy and execution to accelerate category leadership and demand for Armis Centrix™, the Armis Cyber Exposure Management Platform. During the next phase of Armis’ expansion, he will scale the global marketing organization and help further drive the company’s rapid growth and market penetration. “As we enter our next chapter of hyper-growth, I'm thrilled to have Simon joining our leadership team,” said Yevgeny Dibrov, CEO and Co-Founder of Armis. “Simon will be instrumental in modernizing our global marketing engine and solidifying Armis as the definitive leader in cyber exposure management. He's a category creator and has a proven track record of leading world-class marketing organizations. He will focus on deepening our engagement with customers and partners, and scale our demand generation pro
Reply Announces a Partnership With Mistral AI to Develop Sovereign and Enterprise-grade Artificial Intelligence Solutions18.3.2026 10:00:00 EET | Press release
Reply [EXM, STAR: REY] today announced a new partnership agreementwithAI leader Mistral AI aimed at accelerating the adoption of local, customisable, secure and enterprise-grade generative AI solutions at scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260318232777/en/ Through this collaboration, Reply and Mistral AI provide a trusted and secure environment on European infrastructures, accelerating the adoption of advanced AI solutions while enabling organizations with stringent regulatory, privacy and data protection requirements to fully leverage generative AI. At the core of the collaboration is a shared vision of frontier AI, designed to enable organizations to adopt AI solutions while ensuring data control, protection of sensitive information, compliance with regulatory requirements and deployment on European infrastructures. By combining Mistral AI’s high-performance AI models with Reply’s expertise in designing
Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates18.3.2026 09:30:00 EET | Press release
Samsung Bioepis Co., Ltd. announced today that the company has entered into a global license, development and commercialization agreement (DCA) with Sandoz for up to five biosimilar candidates under development by Samsung Bioepis, including SB36, a biosimilar candidate referencing Entyvio1 (vedolizumab). The other terms of the agreement remain confidential. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260318826412/en/ Samsung Bioepis office in Songdo, Incheon, Republic of Korea Under the terms of the agreement, Samsung Bioepis will be responsible for development, regulatory registration in key markets, and manufacture of the biosimilars, while Sandoz will be responsible for commercialization in global markets, excluding China, Hong Kong, Taiwan, Macau, and Republic of Korea. “We are very pleased to expand our successful partnership with Sandoz and to secure commercialization agreement for multiple biosimilar assets that ar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom